Gene Editing
Exploring the potential of gene editing to treat diseases caused by genetic mutations
At Sarepta, we are committed to exploring every modality of precision genetic medicine that may help advance our mission to rescue lives otherwise impacted or stolen by rare disease. We believe gene editing, although early, has the potential to revolutionize the treatment of disease caused by genetic mutations.
Gene Editing Technology Applied to Rare Diseases
Sarepta announced plans to build a Gene Editing Innovation Center (GEIC) in Durham, North Carolina. The GEIC will be led by a world-class scientific team made up of Louise Rodino-Klapac, PhD, Sarepta’s Senior Vice President of Gene Therapy and Charlie Gersbach, PhD, Director, Center for Advanced Genomic Technologies, Rooney Family Associate Professor of Biomedical Engineering, Director, Center for Biomolecular and Tissue Engineering, Duke University.